39890-59-0

Upstream product

• 65229-90-5 1-benzoyl-1,2,2a,3,4,5-hexahydro-benz[cd]indol-5-ol 
• 132008-45-8 1-benzoyl-2,2a,3,4-tetrahydro-1H-benz[cd]indol-5-one 
• 124465-55-0 1-benzoyl-1,2,2a,3-tetrahydro-benz[cd]indole 

Downstream Products

• 119640-77-6 1-benzoyl-4-[methyl-(2-methyl-[1,3]dioxolan-2-ylmethyl)-amino]-1,2,2a,3,4,5-hexahydro-benz[cd]indol-5-ol 
• 51867-06-2 1-benzoyl-1,2,2a,3-tetrahydrobenzindol-4-(5H)-one 
• 132619-30-8 (-)-1-Benzoyl-1,2,2a,3,4,5-hexahydrobenzindol-4-amine 
• 132619-31-9 [(2aS,4S,5S)-4-Hydroxy-5-((S)-1-phenyl-ethylamino)-2a,3,4,5-tetrahydro-2H-benzo[cd]indol-1-yl]-phenyl-methanone 
• 132557-12-1 [(2aR,4R,5R)-4-Hydroxy-5-((S)-1-phenyl-ethylamino)-2a,3,4,5-tetrahydro-2H-benzo[cd]indol-1-yl]-phenyl-methanone 
• 118952-56-0 4-(acetonyl-methyl-amino)-1-benzoyl-1,2,2a,3,4,5-hexahydro-benz[cd]indol-5-ol 
• 69380-13-8 (+/-)-1-benzoyl-4-di-n-propylamino-1,2,2a,3,4,5-hexahydrobenz[c,d]indole 
• 69380-12-7 4-amino-1-benzoyl-1,2,2a,3,4,5-hexahydro-benz[cd]indole 
• 110422-09-8 1-benzoyl-4-methylamino-1,2,2a,3,4,5-hexahydro-benz[cd]indol-5-ol 
• 111141-96-9 1-benzoyl-4-dimethylamino-1,2,2a,3,4,5-hexahydro-benz[cd]indol-5-ol 
• 133256-91-4 (+) (2aR,4S)-1-benzoyl-6-iodo-4-(di-n-propylamino)-1,2,2a,3,4,5-hexahydrobenz[cd]indole 
• 136816-12-1 ((2aR,4S)-4-Amino-6-iodo-2a,3,4,5-tetrahydro-2H-benzo[cd]indol-1-yl)-phenyl-methanone 
• 136791-10-1 (2aR,4S)-1-Benzoyl-4-dipropylamino-1,2,2a,3,4,5-hexahydro-benzo[cd]indole-6-carboxylic acid amide 
• 132557-13-2 Phenyl-[(5aS,6aR,7aS)-7-((S)-1-phenyl-ethyl)-5,5a,6,6a,7,7a-hexahydro-4,7-diaza-cyclopropa[e]acenaphthylen-4-yl]-methanone 

Relevant academic research and scientific papers

Synthetic studies toward the partial ergot alkaloid LY228729, a potent 5HT(1A) receptor agonist

Synthetic studies on LY228729 (3) afforded two innovative approaches for the construction of this class of partial ergoline 5HT(1a) receptor agonists. The first synthesis is based upon a diastereoselective epoxidation of racemic olefin 5, followed by ring

Stereoselective Epoxidations and Electrophilic Additions to Partial Ergot Alkaloids and Conformationally-Fixed Styrenes. Experimental and Theoretical Modeling Evidence for the Importance of Torsional Steering as a Stereocontrol Element

Partial ergot alkaloid substrates and related conformationally-fixed styrenes undergo epoxidation, osmium tetraoxide dihydroxylation, and hydrobromination with a level of stereoselectivity which cannot be explained by steric control but is consistent with

4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole

4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]-indole, useful as prolactin inhibitor and in treatment of Parkinsonisn.